Kanwal Pratap Singh Raghav News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kanwal pratap singh raghav. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kanwal Pratap Singh Raghav Today - Breaking & Trending Today

A Review of Anti-HER2 Targeted Agents in Non-Breast Solid Tumors

This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease. ....

South Korea , University Of Washington , United States , Megan Alhadeff , Javlem Overexpression , Thanh Bui , Tiffany Tam , Chemother Pharmacol , Kanwal Pratap Singh Raghav , Salvatore Siena , Van Cutsem , Atsuo Takashima , Daiichi Sankyo , Fred Hutchinson Cancer Center , American Society For Clinical Pathology , American Society Of Clinical Oncology , American Society Of Consultant Pharmacists , Zanidatamab Jazz Pharmaceuticals , Pieris Pharmaceuticals , World Health Organization , Remegen Co , National Comprehensive Cancer Network , University Of Washington Medicine , College Of American Pathologists , American Society , Clinical Oncology ,

DESTINY-CRC02 Trial Continues to Support the Use of T-DXd in HER2+ Metastatic CRC

Kanwal Pratap Singh Raghav MBBS, MD, discusses data from DESTINY-CRC01 that supported the DESTINY-CRC02 trial, key efficacy and safety data from the trial, and the importance of identifying patients with HER2-positive CRC who may benefit from ADCs like T-DXd in clinical practice. ....

United States , Kanwal Pratap Singh Raghav , Daiichi Sankyo , Eisai Merck , Division Of Ambulatory Treatment Centers , Division Of Cancer Medicine , Department Of Gastrointestinal Medical Oncology , University Of Texas Md Anderson Cancer Center , Gastrointestinal Medical Oncology , Cancer Medicine , Ambulatory Treatment Centers , Cancer Center ,